N-(2-(1H-tetrazol-5-yl)phenyl)-4-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamide

ID: ALA4570994

PubChem CID: 155562924

Max Phase: Preclinical

Molecular Formula: C21H16N6O2

Molecular Weight: 384.40

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N#Cc1ccccc1NC(=O)c1ccc(Cc2c[nH]c3nc(N)[nH]c(=O)c23)cc1

Standard InChI:  InChI=1S/C21H16N6O2/c22-10-14-3-1-2-4-16(14)25-19(28)13-7-5-12(6-8-13)9-15-11-24-18-17(15)20(29)27-21(23)26-18/h1-8,11H,9H2,(H,25,28)(H4,23,24,26,27,29)

Standard InChI Key:  WAVUBBWBRXZLDW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   27.9001   -5.0517    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.9001   -5.8689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6053   -6.2734    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.6053   -4.6390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3106   -5.0517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3151   -5.8654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0903   -6.1126    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.5650   -5.4517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0831   -4.7961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6053   -3.8218    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.1930   -6.2785    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.3313   -4.0175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1297   -3.8432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6764   -4.4510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4741   -4.2772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7231   -3.4980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1681   -2.8923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3725   -3.0692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5212   -3.3226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0722   -3.9261    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.7684   -2.5437    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.5666   -2.3683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1131   -2.9727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9106   -2.7978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1585   -2.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6028   -1.4133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8074   -1.5913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2574   -0.9889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7032   -0.3883    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  4 10  2  0
  2 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 28 29  3  0
 27 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4570994

    ---

Associated Targets(Human)

TYMS Tclin Thymidylate synthase (1651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Bifunctional dihydrofolate reductase-thymidylate synthase (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 384.40Molecular Weight (Monoisotopic): 384.1335AlogP: 2.55#Rotatable Bonds: 4
Polar Surface Area: 140.45Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 11.06CX Basic pKa: 2.25CX LogP: 2.71CX LogD: 2.71
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.43Np Likeness Score: -1.02

References

1. Czyzyk DJ, Valhondo M, Deiana L, Tirado-Rives J, Jorgensen WL, Anderson KS..  (2019)  Structure activity relationship towards design of cryptosporidium specific thymidylate synthase inhibitors.,  183  [PMID:31536894] [10.1016/j.ejmech.2019.111673]

Source